Yvonne Hui Biography and Net Worth

VP, Principal Accounting Officer of Phreesia


Yvonne oversees Phreesia’s revenue recognition and the quote-to-cash operations functions in the finance department. Prior to joining Phreesia, Yvonne spent more than a decade in leadership roles at companies including Google, Spotify, Twitter and Intuitive Surgical, where she was responsible for the global revenue operations, accounting, internal controls, and reporting functions. She also spent nearly a decade as an auditor at PwC. Yvonne is a Certified Public Accountant and holds a BS in Accounting from the University of Hull in the United Kingdom.

What is Yvonne Hui's net worth?

The estimated net worth of Yvonne Hui is at least $624,364.20 as of April 21st, 2025. Ms. Hui owns 23,922 shares of Phreesia stock worth more than $624,364 as of May 14th. This net worth evaluation does not reflect any other investments that Ms. Hui may own. Learn More about Yvonne Hui's net worth.

How do I contact Yvonne Hui?

The corporate mailing address for Ms. Hui and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at investors@phreesia.com. Learn More on Yvonne Hui's contact information.

Has Yvonne Hui been buying or selling shares of Phreesia?

Over the course of the past ninety days, Yvonne Hui has sold $75,217.58 in shares of Phreesia stock. Most recently, Yvonne Hui sold 993 shares of the business's stock in a transaction on Monday, April 21st. The shares were sold at an average price of $23.04, for a transaction totalling $22,878.72. Following the completion of the sale, the insider now directly owns 23,922 shares of the company's stock, valued at $551,162.88. Learn More on Yvonne Hui's trading history.

Who are Phreesia's active insiders?

Phreesia's insider roster includes Edward Cahill (Director), Balaji Gandhi (CFO), Allison Hoffman (General Counsel), Yvonne Hui (VP, Principal Accounting Officer), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Mark Smith (Director), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.

Are insiders buying or selling shares of Phreesia?

In the last twelve months, insiders at the sold shares 79 times. They sold a total of 338,147 shares worth more than $8,720,259.13. The most recent insider tranaction occured on April, 21st when SVP David Linetsky sold 260 shares worth more than $5,990.40. Insiders at Phreesia own 5.8% of the company. Learn More about insider trades at Phreesia.

Information on this page was last updated on 4/21/2025.

Yvonne Hui Insider Trading History at Phreesia

See Full Table

Yvonne Hui Buying and Selling Activity at Phreesia

This chart shows Yvonne Hui's buying and selling at Phreesia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$75ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$50k$0$50kTotal Insider BuyingTotal Insider Selling

Phreesia Company Overview

Phreesia logo
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
Read More

Today's Range

Now: $26.10
Low: $25.81
High: $26.28

50 Day Range

MA: $25.12
Low: $21.90
High: $29.08

2 Week Range

Now: $26.10
Low: $17.07
High: $30.53

Volume

382,595 shs

Average Volume

435,477 shs

Market Capitalization

$1.53 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74